nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—DRD4—schizophrenia	0.199	0.268	CbGaD
L-DOPA—DRD3—schizophrenia	0.171	0.231	CbGaD
L-DOPA—DRD1—schizophrenia	0.168	0.227	CbGaD
L-DOPA—DRD2—schizophrenia	0.119	0.16	CbGaD
L-DOPA—CYP2D6—schizophrenia	0.0838	0.113	CbGaD
L-DOPA—DRD3—telencephalic ventricle—schizophrenia	0.00571	0.0647	CbGeAlD
L-DOPA—DDC—telencephalic ventricle—schizophrenia	0.00557	0.0631	CbGeAlD
L-DOPA—DDC—pineal body—schizophrenia	0.00483	0.0547	CbGeAlD
L-DOPA—DRD1—telencephalic ventricle—schizophrenia	0.00409	0.0463	CbGeAlD
L-DOPA—DDC—blood plasma—schizophrenia	0.00265	0.0301	CbGeAlD
L-DOPA—PSIP1—forebrain—schizophrenia	0.00255	0.0289	CbGeAlD
L-DOPA—DRD2—telencephalic ventricle—schizophrenia	0.00242	0.0274	CbGeAlD
L-DOPA—PSIP1—telencephalon—schizophrenia	0.00234	0.0266	CbGeAlD
L-DOPA—PSIP1—gonad—schizophrenia	0.00196	0.0222	CbGeAlD
L-DOPA—PSIP1—blood—schizophrenia	0.00171	0.0193	CbGeAlD
L-DOPA—PSIP1—midbrain—schizophrenia	0.00168	0.0191	CbGeAlD
L-DOPA—SLC7A8—forebrain—schizophrenia	0.00168	0.019	CbGeAlD
L-DOPA—SLC7A8—telencephalon—schizophrenia	0.00155	0.0175	CbGeAlD
L-DOPA—PSIP1—endocrine gland—schizophrenia	0.00148	0.0167	CbGeAlD
L-DOPA—DDC—forebrain—schizophrenia	0.00145	0.0165	CbGeAlD
L-DOPA—L-Tryptophan—TPH1—schizophrenia	0.00141	0.214	CrCbGaD
L-DOPA—L-Tryptophan—TPH2—schizophrenia	0.00141	0.214	CrCbGaD
L-DOPA—DRD5—forebrain—schizophrenia	0.0014	0.0158	CbGeAlD
L-DOPA—PSIP1—nervous system—schizophrenia	0.00138	0.0157	CbGeAlD
L-DOPA—DDC—telencephalon—schizophrenia	0.00134	0.0151	CbGeAlD
L-DOPA—PSIP1—central nervous system—schizophrenia	0.00133	0.0151	CbGeAlD
L-DOPA—CYP2D6—urine—schizophrenia	0.00133	0.015	CbGeAlD
L-DOPA—PSIP1—cerebellum—schizophrenia	0.0013	0.0148	CbGeAlD
L-DOPA—SLC7A8—gonad—schizophrenia	0.00129	0.0146	CbGeAlD
L-DOPA—DRD5—telencephalon—schizophrenia	0.00129	0.0146	CbGeAlD
L-DOPA—SLC7A5—telencephalon—schizophrenia	0.0012	0.0136	CbGeAlD
L-DOPA—DRD1—forebrain—schizophrenia	0.00107	0.0121	CbGeAlD
L-DOPA—PSIP1—brain—schizophrenia	0.00106	0.012	CbGeAlD
L-DOPA—SLC7A5—gonad—schizophrenia	0.001	0.0113	CbGeAlD
L-DOPA—DRD1—telencephalon—schizophrenia	0.000983	0.0111	CbGeAlD
L-DOPA—SLC7A8—endocrine gland—schizophrenia	0.000975	0.011	CbGeAlD
L-DOPA—DDC—midbrain—schizophrenia	0.00096	0.0109	CbGeAlD
L-DOPA—SLC7A8—nervous system—schizophrenia	0.000912	0.0103	CbGeAlD
L-DOPA—DRD4—brain—schizophrenia	0.000881	0.00997	CbGeAlD
L-DOPA—SLC7A8—central nervous system—schizophrenia	0.000878	0.00995	CbGeAlD
L-DOPA—SLC7A5—blood—schizophrenia	0.000871	0.00986	CbGeAlD
L-DOPA—SLC7A5—midbrain—schizophrenia	0.00086	0.00974	CbGeAlD
L-DOPA—SLC7A8—cerebellum—schizophrenia	0.000859	0.00972	CbGeAlD
L-DOPA—DDC—endocrine gland—schizophrenia	0.000843	0.00955	CbGeAlD
L-DOPA—DRD5—endocrine gland—schizophrenia	0.000811	0.00918	CbGeAlD
L-DOPA—DRD3—nervous system—schizophrenia	0.00081	0.00917	CbGeAlD
L-DOPA—DDC—nervous system—schizophrenia	0.000789	0.00894	CbGeAlD
L-DOPA—DRD3—central nervous system—schizophrenia	0.00078	0.00883	CbGeAlD
L-DOPA—SLC16A10—gonad—schizophrenia	0.000765	0.00867	CbGeAlD
L-DOPA—DDC—central nervous system—schizophrenia	0.00076	0.00861	CbGeAlD
L-DOPA—DRD5—nervous system—schizophrenia	0.000759	0.0086	CbGeAlD
L-DOPA—SLC7A5—endocrine gland—schizophrenia	0.000755	0.00855	CbGeAlD
L-DOPA—DRD5—central nervous system—schizophrenia	0.000731	0.00828	CbGeAlD
L-DOPA—SLC7A5—nervous system—schizophrenia	0.000707	0.00801	CbGeAlD
L-DOPA—DRD1—midbrain—schizophrenia	0.000706	0.00799	CbGeAlD
L-DOPA—SLC7A8—brain—schizophrenia	0.000697	0.0079	CbGeAlD
L-DOPA—CYP2D6—blood plasma—schizophrenia	0.000692	0.00784	CbGeAlD
L-DOPA—SLC7A5—central nervous system—schizophrenia	0.000681	0.00771	CbGeAlD
L-DOPA—SLC16A10—blood—schizophrenia	0.000667	0.00755	CbGeAlD
L-DOPA—SLC7A5—cerebellum—schizophrenia	0.000665	0.00753	CbGeAlD
L-DOPA—DRD2—forebrain—schizophrenia	0.000631	0.00715	CbGeAlD
L-DOPA—SLC15A1—endocrine gland—schizophrenia	0.000627	0.0071	CbGeAlD
L-DOPA—DRD3—brain—schizophrenia	0.000619	0.00701	CbGeAlD
L-DOPA—L-Tyrosine—TH—schizophrenia	0.00061	0.0929	CrCbGaD
L-DOPA—DDC—brain—schizophrenia	0.000603	0.00683	CbGeAlD
L-DOPA—DRD2—telencephalon—schizophrenia	0.00058	0.00657	CbGeAlD
L-DOPA—DRD5—brain—schizophrenia	0.00058	0.00657	CbGeAlD
L-DOPA—DRD1—nervous system—schizophrenia	0.00058	0.00657	CbGeAlD
L-DOPA—SLC16A10—endocrine gland—schizophrenia	0.000578	0.00655	CbGeAlD
L-DOPA—DRD1—central nervous system—schizophrenia	0.000558	0.00632	CbGeAlD
L-DOPA—SLC7A5—brain—schizophrenia	0.00054	0.00612	CbGeAlD
L-DOPA—SLC16A10—cerebellum—schizophrenia	0.000509	0.00577	CbGeAlD
L-DOPA—DRD1—brain—schizophrenia	0.000443	0.00502	CbGeAlD
L-DOPA—DRD2—midbrain—schizophrenia	0.000417	0.00472	CbGeAlD
L-DOPA—Methyldopa—COMT—schizophrenia	0.000414	0.063	CrCbGaD
L-DOPA—CYP2D6—forebrain—schizophrenia	0.000379	0.0043	CbGeAlD
L-DOPA—DRD2—endocrine gland—schizophrenia	0.000366	0.00415	CbGeAlD
L-DOPA—L-Phenylalanine—TH—schizophrenia	0.000354	0.0539	CrCbGaD
L-DOPA—CYP2D6—telencephalon—schizophrenia	0.000349	0.00395	CbGeAlD
L-DOPA—DRD2—nervous system—schizophrenia	0.000343	0.00388	CbGeAlD
L-DOPA—Norepinephrine—SLC18A2—schizophrenia	0.000341	0.0519	CrCbGaD
L-DOPA—DRD2—central nervous system—schizophrenia	0.00033	0.00374	CbGeAlD
L-DOPA—DRD2—cerebellum—schizophrenia	0.000322	0.00365	CbGeAlD
L-DOPA—DRD2—brain—schizophrenia	0.000262	0.00297	CbGeAlD
L-DOPA—CYP2D6—blood—schizophrenia	0.000254	0.00287	CbGeAlD
L-DOPA—CYP2D6—endocrine gland—schizophrenia	0.00022	0.00249	CbGeAlD
L-DOPA—CYP2D6—nervous system—schizophrenia	0.000206	0.00233	CbGeAlD
L-DOPA—Dopamine—COMT—schizophrenia	0.000202	0.0308	CrCbGaD
L-DOPA—CYP2D6—central nervous system—schizophrenia	0.000198	0.00224	CbGeAlD
L-DOPA—CYP2D6—cerebellum—schizophrenia	0.000194	0.00219	CbGeAlD
L-DOPA—Dopamine—DRD4—schizophrenia	0.000164	0.0249	CrCbGaD
L-DOPA—CYP2D6—brain—schizophrenia	0.000157	0.00178	CbGeAlD
L-DOPA—Dopamine—MAOA—schizophrenia	0.000152	0.0232	CrCbGaD
L-DOPA—Dopamine—HTR7—schizophrenia	0.00015	0.0229	CrCbGaD
L-DOPA—Dopamine—DRD3—schizophrenia	0.000141	0.0215	CrCbGaD
L-DOPA—Dopamine—DRD1—schizophrenia	0.000139	0.0211	CrCbGaD
L-DOPA—Dopamine—SLC6A3—schizophrenia	0.000131	0.02	CrCbGaD
L-DOPA—Epinephrine—TNF—schizophrenia	0.000119	0.0182	CrCbGaD
L-DOPA—Dopamine—HTR1A—schizophrenia	0.000115	0.0175	CrCbGaD
L-DOPA—Norepinephrine—DRD2—schizophrenia	0.000105	0.016	CrCbGaD
L-DOPA—Dopamine—SLC6A4—schizophrenia	9.83e-05	0.015	CrCbGaD
L-DOPA—Dopamine—DRD2—schizophrenia	9.77e-05	0.0149	CrCbGaD
L-DOPA—Norepinephrine—CYP1A2—schizophrenia	9.63e-05	0.0147	CrCbGaD
L-DOPA—Dopamine—CYP1A2—schizophrenia	8.95e-05	0.0136	CrCbGaD
L-DOPA—Epinephrine—CYP1A2—schizophrenia	8.73e-05	0.0133	CrCbGaD
L-DOPA—Liothyronine—ABCB1—schizophrenia	7.2e-05	0.011	CrCbGaD
L-DOPA—Dopamine—CYP2D6—schizophrenia	6.91e-05	0.0105	CrCbGaD
L-DOPA—DRD1—Signaling Pathways—GRM5—schizophrenia	1.29e-05	7.87e-05	CbGpPWpGaD
L-DOPA—DDC—Metabolism—MTHFR—schizophrenia	1.29e-05	7.86e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GFAP—schizophrenia	1.29e-05	7.85e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NTS—schizophrenia	1.29e-05	7.84e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PDE4B—schizophrenia	1.28e-05	7.79e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GRM5—schizophrenia	1.27e-05	7.76e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR1B—schizophrenia	1.26e-05	7.71e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—OXT—schizophrenia	1.26e-05	7.71e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CCKAR—schizophrenia	1.26e-05	7.66e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—DRD3—schizophrenia	1.25e-05	7.64e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TLE3—schizophrenia	1.25e-05	7.62e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—CNR1—schizophrenia	1.24e-05	7.57e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ACSL6—schizophrenia	1.24e-05	7.56e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SLC27A5—schizophrenia	1.24e-05	7.56e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TLE3—schizophrenia	1.23e-05	7.52e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ADORA2A—schizophrenia	1.22e-05	7.43e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR1A—schizophrenia	1.22e-05	7.42e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—DRD4—schizophrenia	1.22e-05	7.42e-05	CbGpPWpGaD
L-DOPA—PSIP1—Disease—AKT1—schizophrenia	1.21e-05	7.39e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR7—schizophrenia	1.21e-05	7.39e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—DRD2—schizophrenia	1.21e-05	7.39e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RGS4—schizophrenia	1.21e-05	7.37e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—RTN4—schizophrenia	1.21e-05	7.37e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GRM3—schizophrenia	1.21e-05	7.37e-05	CbGpPWpGaD
L-DOPA—DDC—Metabolism—APOE—schizophrenia	1.2e-05	7.32e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PLA2G4A—schizophrenia	1.2e-05	7.31e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—NPS—schizophrenia	1.2e-05	7.3e-05	CbGpPWpGaD
L-DOPA—DDC—Metabolism—APOA1—schizophrenia	1.19e-05	7.24e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR6—schizophrenia	1.19e-05	7.23e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DAO—schizophrenia	1.18e-05	7.21e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCK—schizophrenia	1.18e-05	7.19e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2C—schizophrenia	1.18e-05	7.16e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—DRD1—schizophrenia	1.18e-05	7.16e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—FGA—schizophrenia	1.17e-05	7.12e-05	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—HTR2A—schizophrenia	1.17e-05	7.12e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCK—schizophrenia	1.16e-05	7.1e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—CNR1—schizophrenia	1.16e-05	7.08e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PDE4B—schizophrenia	1.15e-05	7.01e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MAG—schizophrenia	1.15e-05	6.98e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PRL—schizophrenia	1.15e-05	6.98e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NPY—schizophrenia	1.14e-05	6.94e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NOTCH4—schizophrenia	1.14e-05	6.94e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ATP2A2—schizophrenia	1.14e-05	6.94e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—DRD3—schizophrenia	1.14e-05	6.94e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PDE4B—schizophrenia	1.14e-05	6.92e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PNP—schizophrenia	1.13e-05	6.92e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR7—schizophrenia	1.13e-05	6.91e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CCKAR—schizophrenia	1.13e-05	6.9e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CCKAR—schizophrenia	1.12e-05	6.81e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—DRD4—schizophrenia	1.11e-05	6.73e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR1B—schizophrenia	1.1e-05	6.7e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—OXT—schizophrenia	1.1e-05	6.7e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADORA2A—schizophrenia	1.1e-05	6.69e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADORA2A—schizophrenia	1.08e-05	6.6e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—PLA2G4A—schizophrenia	1.08e-05	6.58e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—S100B—schizophrenia	1.07e-05	6.5e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PLA2G4A—schizophrenia	1.06e-05	6.49e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR2A—schizophrenia	1.06e-05	6.47e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR1A—schizophrenia	1.06e-05	6.45e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—CNR1—schizophrenia	1.06e-05	6.43e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NDUFV2—schizophrenia	1.06e-05	6.43e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—FGA—schizophrenia	1.05e-05	6.41e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR2A—schizophrenia	1.05e-05	6.41e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CHRM1—schizophrenia	1.05e-05	6.39e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NPS—schizophrenia	1.04e-05	6.35e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—FGA—schizophrenia	1.04e-05	6.33e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR2A—schizophrenia	1.04e-05	6.32e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR7—schizophrenia	1.03e-05	6.27e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NPY—schizophrenia	1.03e-05	6.25e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ATP2A2—schizophrenia	1.03e-05	6.25e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NOTCH4—schizophrenia	1.03e-05	6.25e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DRD1—schizophrenia	1.02e-05	6.23e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2C—schizophrenia	1.02e-05	6.23e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL3RA—schizophrenia	1.02e-05	6.23e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ERBB4—schizophrenia	1.02e-05	6.22e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ATP2A2—schizophrenia	1.01e-05	6.17e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NPY—schizophrenia	1.01e-05	6.17e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NOTCH4—schizophrenia	1.01e-05	6.17e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NRG3—schizophrenia	9.97e-06	6.08e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TLE1—schizophrenia	9.97e-06	6.08e-05	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—TP53—schizophrenia	9.97e-06	6.08e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NTRK2—schizophrenia	9.94e-06	6.06e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PIP4K2A—schizophrenia	9.92e-06	6.04e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DRD3—schizophrenia	9.9e-06	6.03e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—OXT—schizophrenia	9.89e-06	6.03e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR1B—schizophrenia	9.89e-06	6.03e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GFAP—schizophrenia	9.86e-06	6.01e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR1B—schizophrenia	9.76e-06	5.95e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—OXT—schizophrenia	9.76e-06	5.95e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GRM5—schizophrenia	9.75e-06	5.94e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PLA2G4A—schizophrenia	9.6e-06	5.85e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR2A—schizophrenia	9.55e-06	5.82e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR1A—schizophrenia	9.52e-06	5.8e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TLE3—schizophrenia	9.44e-06	5.75e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR2A—schizophrenia	9.42e-06	5.74e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—NRG1—schizophrenia	9.42e-06	5.74e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR1A—schizophrenia	9.4e-06	5.73e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NPS—schizophrenia	9.38e-06	5.72e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MEF2C—schizophrenia	9.33e-06	5.69e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NPS—schizophrenia	9.25e-06	5.64e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2C—schizophrenia	9.2e-06	5.6e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CNR1—schizophrenia	9.17e-06	5.59e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD1—schizophrenia	9.08e-06	5.53e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2C—schizophrenia	9.08e-06	5.53e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—YWHAZ—schizophrenia	9.02e-06	5.5e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CYP26B1—schizophrenia	8.97e-06	5.47e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR7—schizophrenia	8.95e-06	5.45e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DRD2—schizophrenia	8.95e-06	5.45e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NTRK2—schizophrenia	8.95e-06	5.45e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCK—schizophrenia	8.91e-06	5.43e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD3—schizophrenia	8.91e-06	5.43e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NTRK2—schizophrenia	8.83e-06	5.38e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ERBB3—schizophrenia	8.82e-06	5.38e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PDE4B—schizophrenia	8.69e-06	5.29e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD4—schizophrenia	8.65e-06	5.27e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CCKAR—schizophrenia	8.55e-06	5.21e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD4—schizophrenia	8.53e-06	5.2e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR2A—schizophrenia	8.49e-06	5.17e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PRL—schizophrenia	8.45e-06	5.15e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADORA2A—schizophrenia	8.29e-06	5.05e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CNR1—schizophrenia	8.26e-06	5.03e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PLA2G4A—schizophrenia	8.15e-06	4.97e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CNR1—schizophrenia	8.15e-06	4.96e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD2—schizophrenia	8.06e-06	4.91e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR7—schizophrenia	8.06e-06	4.91e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—TPH1—schizophrenia	8e-06	4.87e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GCLM—schizophrenia	8e-06	4.87e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD2—schizophrenia	7.95e-06	4.84e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR7—schizophrenia	7.95e-06	4.84e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—FGA—schizophrenia	7.95e-06	4.84e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR2A—schizophrenia	7.94e-06	4.84e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—APOE—schizophrenia	7.9e-06	4.81e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—S100B—schizophrenia	7.88e-06	4.8e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—APOA1—schizophrenia	7.8e-06	4.76e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NPY—schizophrenia	7.74e-06	4.72e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NOTCH4—schizophrenia	7.74e-06	4.72e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ATP2A2—schizophrenia	7.74e-06	4.72e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PRL—schizophrenia	7.61e-06	4.64e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ESR1—schizophrenia	7.54e-06	4.59e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ERBB4—schizophrenia	7.53e-06	4.59e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PRKD1—schizophrenia	7.52e-06	4.58e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PRL—schizophrenia	7.51e-06	4.57e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—OXT—schizophrenia	7.47e-06	4.55e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR1B—schizophrenia	7.47e-06	4.55e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2A—schizophrenia	7.21e-06	4.39e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR1A—schizophrenia	7.19e-06	4.38e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—S100B—schizophrenia	7.09e-06	4.32e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PLA2G4A—schizophrenia	7.08e-06	4.32e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NPS—schizophrenia	7.08e-06	4.31e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—S100B—schizophrenia	7e-06	4.26e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NRG1—schizophrenia	6.95e-06	4.24e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD1—schizophrenia	6.94e-06	4.23e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2C—schizophrenia	6.94e-06	4.23e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MEF2C—schizophrenia	6.89e-06	4.2e-05	CbGpPWpGaD
L-DOPA—DDC—Metabolism—EP300—schizophrenia	6.85e-06	4.17e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—GSK3B—schizophrenia	6.84e-06	4.17e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ERBB4—schizophrenia	6.78e-06	4.13e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NTRK2—schizophrenia	6.76e-06	4.12e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD3—schizophrenia	6.73e-06	4.1e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ERBB4—schizophrenia	6.69e-06	4.08e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—YWHAZ—schizophrenia	6.66e-06	4.06e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD4—schizophrenia	6.53e-06	3.98e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ERBB3—schizophrenia	6.51e-06	3.97e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PLA2G4A—schizophrenia	6.38e-06	3.88e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PLA2G4A—schizophrenia	6.29e-06	3.83e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GAPDH—schizophrenia	6.27e-06	3.82e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2A—schizophrenia	6.27e-06	3.82e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NRG1—schizophrenia	6.26e-06	3.81e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CNR1—schizophrenia	6.23e-06	3.8e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CLOCK—schizophrenia	6.22e-06	3.79e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MEF2C—schizophrenia	6.2e-06	3.78e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NRG1—schizophrenia	6.17e-06	3.76e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MEF2C—schizophrenia	6.12e-06	3.73e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR7—schizophrenia	6.08e-06	3.71e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—TPH2—schizophrenia	6.06e-06	3.69e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CACNB2—schizophrenia	6.06e-06	3.69e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—YWHAZ—schizophrenia	5.99e-06	3.65e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DPYD—schizophrenia	5.96e-06	3.63e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—YWHAZ—schizophrenia	5.91e-06	3.6e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ERBB3—schizophrenia	5.86e-06	3.57e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—APOE—schizophrenia	5.83e-06	3.55e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ERBB3—schizophrenia	5.78e-06	3.52e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—APOA1—schizophrenia	5.76e-06	3.51e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRL—schizophrenia	5.74e-06	3.5e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2A—schizophrenia	5.64e-06	3.44e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2A—schizophrenia	5.57e-06	3.39e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ESR1—schizophrenia	5.56e-06	3.39e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CACNA1C—schizophrenia	5.54e-06	3.38e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PIK3C2A—schizophrenia	5.4e-06	3.29e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—S100B—schizophrenia	5.35e-06	3.26e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—APOE—schizophrenia	5.25e-06	3.2e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—APOA1—schizophrenia	5.19e-06	3.16e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—APOE—schizophrenia	5.18e-06	3.15e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ERBB4—schizophrenia	5.12e-06	3.12e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—APOA1—schizophrenia	5.12e-06	3.12e-05	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—AKT1—schizophrenia	5.07e-06	3.09e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—GSK3B—schizophrenia	5.05e-06	3.07e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ESR1—schizophrenia	5.01e-06	3.05e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ESR1—schizophrenia	4.94e-06	3.01e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SNAP25—schizophrenia	4.84e-06	2.95e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PLA2G4A—schizophrenia	4.81e-06	2.93e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NRG1—schizophrenia	4.73e-06	2.88e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MEF2C—schizophrenia	4.68e-06	2.85e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—AKT1—schizophrenia	4.6e-06	2.8e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GSK3B—schizophrenia	4.54e-06	2.77e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—YWHAZ—schizophrenia	4.53e-06	2.76e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EP300—schizophrenia	4.5e-06	2.74e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GSK3B—schizophrenia	4.48e-06	2.73e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ERBB3—schizophrenia	4.43e-06	2.7e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CYP1A2—schizophrenia	4.38e-06	2.67e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—TH—schizophrenia	4.32e-06	2.63e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2A—schizophrenia	4.26e-06	2.6e-05	CbGpPWpGaD
L-DOPA—DDC—Metabolism—AKT1—schizophrenia	4.14e-06	2.52e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—APOE—schizophrenia	3.96e-06	2.41e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—APOA1—schizophrenia	3.92e-06	2.39e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ESR1—schizophrenia	3.78e-06	2.3e-05	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—AKT1—schizophrenia	3.74e-06	2.28e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—COMT—schizophrenia	3.67e-06	2.24e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTP1—schizophrenia	3.65e-06	2.23e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MAOA—schizophrenia	3.65e-06	2.22e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ABCB1—schizophrenia	3.46e-06	2.11e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GSK3B—schizophrenia	3.43e-06	2.09e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—AKT1—schizophrenia	3.4e-06	2.07e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—AKT1—schizophrenia	3.37e-06	2.05e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PLA2G4A—schizophrenia	3.36e-06	2.05e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTM1—schizophrenia	3.36e-06	2.05e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—AKT1—schizophrenia	3.32e-06	2.02e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EP300—schizophrenia	3.32e-06	2.02e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TP53—schizophrenia	3.22e-06	1.96e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—AKT1—schizophrenia	3.06e-06	1.86e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—AKT1—schizophrenia	3.02e-06	1.84e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EP300—schizophrenia	2.99e-06	1.82e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MTHFR—schizophrenia	2.97e-06	1.81e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EP300—schizophrenia	2.95e-06	1.8e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—APOE—schizophrenia	2.76e-06	1.68e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—APOA1—schizophrenia	2.73e-06	1.66e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—AKT1—schizophrenia	2.72e-06	1.66e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—AKT1—schizophrenia	2.54e-06	1.55e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TP53—schizophrenia	2.38e-06	1.45e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—AKT1—schizophrenia	2.31e-06	1.41e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EP300—schizophrenia	2.26e-06	1.38e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TP53—schizophrenia	2.14e-06	1.3e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TP53—schizophrenia	2.11e-06	1.29e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—AKT1—schizophrenia	2.01e-06	1.22e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—AKT1—schizophrenia	1.81e-06	1.1e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—AKT1—schizophrenia	1.78e-06	1.09e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TP53—schizophrenia	1.62e-06	9.84e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—EP300—schizophrenia	1.57e-06	9.59e-06	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AKT1—schizophrenia	1.36e-06	8.31e-06	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—AKT1—schizophrenia	9.52e-07	5.8e-06	CbGpPWpGaD
